Considerations on the mechanics and sample sizes for early trials of targeted agents and immunotherapy in oncology
Read article on trial design and sample sizes for early trials Written by Elisabeth Coart and Everardo D. Saad, Consulting…
Featured Articles
Featured Articles
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cras vel sagittis libero, a lacinia nisi. Interdum et malesuada fames ac ante ipsum primis in faucibus. Donec nec nisl turpis. Pellentesque pretium pellentesque maximus. Nam efficitur massa justo, eget laoreet odio congue convallis. Proin sagittis mauris sit amet justo cursus, sit amet porta eros eleifend. Nullam felis tortor, pharetra a consequat eget, luctus non massa. Cras sed efficitur felis, sollicitudin gravida eros. Mauris congue efficitur tempor.
Renseigner une description via Articles > Categories > Featured Articles > Champ 'Description' pour remplacer ce Lorem ipsum.
Clinical Development Trends
May 25, 2021
In addition to pharmaceutical and biopharmaceutical sponsors outsourcing clinical trials to Contract Research Organizations (CROs) to gain flexibility and speed…
Personalized Medicine: A Work in Progress
Dr. Everardo Saad, Medical Director of IDDI contributed to an article on Personalized Medicine published in the June issue of…
Commanders & Chiefs: Clinical Services C-Suite – Pharmavoice
IDDI contributed to the Pharmavoice article: Commanders & Chiefs: Clinical Services C-Suite, February, 2021 CROs and other clinical services companies…
Statistical Considerations for Trials in Adjuvant Treatment of Colorectal Cancer
Improvements in the treatment of patients with cancer largely depend on clinical trials comparing a new intervention with a previous…
Assessing Treatment Benefit in Immuno-oncology
Adaptations to tumor response and progression criteria for immune therapies. Abstract Immuno-oncology is a buoyant field of research, with recently…
Finding the one: How to choose a Clinical Partner in Sea of Service Providers
What should companies look for when selecting a CRO clinicalpartner? Just one in ten drug candidates are successful in clinical…
Integration of Biomarker Validation in Clinical Development in Oncology
The development and qualification of biomarkers are keys to the future of drug development and precision medicine, particularly in oncology….
IDDI in Contract Pharma
Insight on the pharma and biopharma trends impacting CROs, Outsourcing in today’s market, and advances in clinical research. READ IDDI…
Surrogate endpoints create potential, require statistical validation
Transforming statistical data into a surrogate endpoint can enable comprehension of trial results sooner than usual, but few make the…